Headline
The latest stories from AHA Today.
The Food and Drug Administration's Office of Minority Health and Health Equity released two videos on COVID-19 vaccines and the importance of communities of color who have been disproportionately impacted by COVID-19 getting vaccinated to protect themselves and loved ones from the virus.
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines, and help train current and future health care personnel to prevent and control infectious disease.
President Biden will sign an executive order to create more resilient and secure supply chains for critical and essential goods, the White House announced, calling last year’s shortages of personal protective equipment for front-line health care workers “unacceptable.”
Data submitted to the Food and Drug Administration confirms that Johnson & Johnson’s COVID-19 vaccine candidate is safe and effective.
Judy Rich, president and CEO of Tucson Medical Center in Arizona, said on a call with media that on top of nursing costs, which in some instances have jumped from $48 per hour to $150 per hour, her hospital is even funding a kindergarten-through-sixth grade school so staff can come to work.
The Coalition to Protect America’s Health Care, of which the AHA is a founding member, has launched a new TV ad urging Congress to provide critical resources to help hospitals and health systems as they continue the battle against COVID-19.
The Center for Internet Security began offering its Malicious Domain Blocking and Reporting ransomware protection service free to private hospitals.
State and regional hospital associations filed friend-of-the-court briefs supporting AHA’s request for the U.S. Supreme Court to review two circuit court decisions last July that threaten continued access to care for hospital outpatients in need.
The Department of Veterans Affairs’ Community Care Network now offers COVID-19 vaccinations to eligible veterans nationwide at its urgent care and retail pharmacy locations, the agency reports.
Johnson & Johnson plans to deliver 20 million doses of its COVID-19 vaccine candidate to the United States by the end of March if the Food and Drug Administration authorizes emergency use of the single-dose vaccine, a company executive told a House subcommittee at a hearing on expanding vaccine…